Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep study
HBsAg prevalence was low overall, but disproportionately higher among First Nations people and people born overseas. Lower likelihood of HBV in people injecting drugs might be explained by higher chance of spontaneous clearance in adulthood or high-coverage HBV vaccination programs for children and adolescents, and subsequent immunity in many people by the time they start injecting drugs. Prison-based HBV testing uptake and vaccination coverage were sub-optimal. Targeted, jurisdiction- and population-specific strategies are needed to improve prison-based HBV care.
Authors
- Andrew R. Lloyd (ORCID: https://orcid.org/0000-0001-6277-8887)
- Yumi Sheehan (ORCID: https://orcid.org/0000-0001-6027-3535)
- Behzad Hajarizadeh (ORCID: https://orcid.org/0000-0003-2212-2028)
- Jason Grebely (ORCID: https://orcid.org/0000-0002-1833-2017)
- Gregory J. Dore (ORCID: https://orcid.org/0000-0002-4741-2622)
- Rugiatu Bah (ORCID: https://orcid.org/0009-0003-5971-0066)
- Xiaoying Li (ORCID: https://orcid.org/0009-0007-1788-0760)
- Chloe Montague
Institutions
- UNSW Sydney (AU)
Publication Details
- Journal
- International Journal of Drug Policy
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1016/j.drugpo.2025.105035
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00